ArticleBMC health services research2021

A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany.

Florian Jakobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.